Musk’s bladder medication he’s selling on the internet a scam?

1. What the reporting actually establishes about ketamine and Musk’s bladder

Multiple outlets repeated a New York Times investigation that cited unnamed sources saying Musk told associates he was taking so much ketamine that it affected his bladder—a known consequence of chronic ketamine abuse—an allegation the Times said came from people familiar with his activities and photographs it reviewed ^[1]. The Times’ account, summarized widely, described intense use of ketamine alongside other substances and noted photographs of a medication box Musk allegedly carried ^{[1] [5]}.

2. Denials, responses and a public test image

Musk has denied the allegations, calling the reporting false, and has publicly mocked elements of the coverage, including posting what appeared to be a negative urinary drug test image with the caption “lol” on his social platform ^{[3] [2]}. The New York Times defended its reporting and said it offered Musk chances to comment before publication, framing his social-media rebuttals as distraction rather than substantive refutation ^[4].

3. Medical context: ketamine and bladder problems

Chronic, high-dose ketamine exposure is associated in medical literature with urinary tract and bladder dysfunction; outlets reporting the Times story noted that bladder effects are a known consequence of chronic ketamine abuse, a point used to contextualize the Times’ allegation about Musk’s statements to associates ^{[1] [6]}. The sources do not, however, provide medical records or direct clinical proof linking Musk’s condition to ketamine beyond the accounts of unnamed sources and reported self-disclosures to confidants ^[1].

4. What’s missing for the specific “selling medication online” claim

None of the supplied sources say Musk is marketing or selling a bladder medication on the internet; they focus on alleged recreational and prescribed drug use, his role advising the Trump administration, and his public rebuttals ^{[1] [5] [3]}. Because the claim about an online product is absent from these reports, it cannot be verified or debunked on the basis of the provided material, and any answer about a “scam” would require independent evidence—sales listings, product labels, regulatory filings, consumer complaints, or investigative reporting covering the purported product—that are not present here ^{[1] [2]}.

5. Motives, agendas and why the gap matters

The New York Times’ investigation relied on unnamed sources and documents and has been defended by the paper; Musk’s public denials and social-media theatrics fit a pattern of high-profile figures contesting anonymous-sourced exposés ^{[4] [3]}. Outlets that amplified the Times’ findings repeatedly emphasized the potential public-interest angles—Musk’s influence in government and whether he was impaired while advising—while critics and allies framed coverage as politically motivated or inaccurate, an implicit agenda battle visible across reporting ^{[1] [6] [4]}.

6. Bottom line for readers trying to judge “a scam”

Based on the provided reporting, there is credible mainstream coverage alleging Musk’s heavy ketamine use and that it affected his bladder, plus Musk’s denial and a posted negative test image, but there is no sourced evidence here that he is selling a bladder medication online or that any such product is fraudulent ^{[1] [2] [3] [4]}. Determining whether a specific product is a scam requires concrete documentation of the product, its claims, marketing channels, purchasers’ experiences and regulatory status—none of which appear in these sources ^{[1] [2]}.